Vitamin C and Antioxidants Research
Open access
Peer reviewed
Abstract
Abstract
Previous randomized trials of vitamin C in sepsis have reported conflicting findings, but whether the effect of vitamin C varies according to septic shock status remains unclear. We aimed to evaluate the effect of megadose vitamin C in sepsis and explore whether treatment effect differed according to septic shock status. CEMVIS was a multicenter, randomized, single-blind, placebo-controlled trial conducted in four tertiary hospitals in China. Adults meeting Sepsis-3 criteria were randomly assigned (1:1) to receive intravenous vitamin C (12 g every 12 h for 4 days) or placebo using stratified randomization according to septic shock status. Patients were analyzed according to the modified intention-to-treat principle. The primary outcome was 28-day mortality. Between Feb 8, 2022, and Dec 25, 2024, 114 patients in the vitamin C group and 117 in the placebo group were included in the modified intention-to-treat population. 28-day mortality did not differ significantly between groups (35/114 [30.7%] vs 36/116 [31.0%]; odds ratio 0.99, 95% CI 0.56–1.74; p = 0.97). No significant differences were observed in the duration of mechanical ventilation, vasopressor therapy, and renal replacement therapy, or in changes in SOFA scores over 96 hours. Prespecified subgroup analyses showed significant interaction according to septic shock status (P for interaction = 0.026), with the treatment effects on 28-day mortality numerically favoring vitamin C among patients without septic shock (15.4% vs 34%) and numerically favoring placebo among those with septic shock (38.7% vs 29%). Hypernatremia occurred more frequently in the vitamin C group (40/114 [35.1%] vs 24/117 [20.5%]; p = 0.02). Exploratory restricted cubic spline analyses showed that increasing lactate levels were associated with a progressive shift in treatment effect from potential benefit toward potential harm. Post hoc Bayesian analyses further provided probabilistic characterization of the potential treatment effect according to septic shock status. The results of this trial do not support the routine use of megadose vitamin C to reduce 28-day mortality in patients with sepsis. Treatment effects may vary according to septic shock status. This trial was registered with ClinicalTrials.gov on 3 January 2022 (identifier: NCT05194189).
Direct answer
What can I do from this paper page?
Use this page to scan "Effect of megadose vitamin C in patients with sepsis: the CEMVIS randomized clinical trial" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Vitamin C and Antioxidants Research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Guan2026Effect,
title = {Effect of megadose vitamin C in patients with sepsis: the CEMVIS randomized clinical trial},
author = {Jianbin Guan and Guizhong Wang and Zhihui Liang and Wei Peng and Xifan Yang and Shaowu Chen and Hongbin Hu and Dezhi Zeng and Guoneng Gan and Miaolian Chen and Ruixia Huang and Haozhao Huang and Limei Chen and Ru Yang and Wenjuan Peng and Xiaoqin Cheng and Yingxin Tang and Zhenhua Zeng and Shaoqing Cai and 莫碧华 and Zhanguo Liu},
journal = {Critical Care},
year = {2026},
doi = {10.1186/s13054-026-06280-7},
url = {https://doi.org/10.1186/s13054-026-06280-7}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Vitamin C and Antioxidants Research papers?
Follow Vitamin C and Antioxidants Research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Effect of megadose vitamin C in patients with sepsis: the CEMVIS randomized clinical trial. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app